This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Pranavkumar Shivkumar: Innovator in Antifungal Compounds
Introduction
Pranavkumar Shivkumar is a notable inventor based in Angol, Belgaum, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal compounds. His innovative work has led to the creation of novel compounds that hold promise for medical applications.
Latest Patents
Pranavkumar Shivkumar holds a patent for "Thienopyridine analogues with antifungal activity and process thereof." This invention relates to novel antifungal compounds and their pharmaceutically acceptable salts. The compounds feature imidazolyl or benzimidazolyl derivatives, which can be substituted at various positions to enhance their antifungal properties. The patent highlights the versatility of these compounds, allowing for a range of substitutions that can optimize their effectiveness.
Career Highlights
Throughout his career, Pranavkumar has focused on the synthesis and application of pharmaceutical compounds. His dedication to research and innovation has resulted in a patent that contributes to the ongoing fight against fungal infections. His work exemplifies the intersection of chemistry and medicine, showcasing how innovative thinking can lead to practical solutions in healthcare.
Collaborations
Pranavkumar has collaborated with notable colleagues such as Ravindra S Shetty and Vithal Madhavrao Kulkarni. These collaborations have likely enriched his research and contributed to the successful development of his patented compounds.
Conclusion
Pranavkumar Shivkumar's contributions to the field of antifungal compounds demonstrate the importance of innovation in pharmaceuticals. His patent reflects a commitment to advancing medical science and improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile